User:Sabrinapercc/sandbox

Suzie Chen
Suzie Chen is a Professor and Department Chair of Chemical Biology at Rutgers University in New Brunswick, New Jersey. Chen currently works at the Susan Lehman Cullman Laboratory for Cancer Research and Ernest Mario School of Pharmacy.

Early Life and Education
She arrived to America with her parents at the age of 13 from Taiwan and she wanted to learn the english language but schools didn't offer English as a second language. Her years of schools were difficult for her expect for math.

Chen always knew she wanted to start college and initially her goal was to be an airline stewardess, but after her first plane ride with the experience of air sickness, she decide to change her career path. During her junior year in high school, she was involved in sciences and with the help of her best friend's mother she earned her first job with Dr. Frank Ruddle at Yale University. She worked alongside him at his laboratory and remain to for Dr. Ruddle throughout her remaining years in high school and college.

During Chen's graduation, she graduated with a B.S in mathematics, but was still unsure with her future and still worked for Dr. Ruddle lab for another additional two years. Everyone around her suggested to have a graduates degree in biological sciences. So she attended Albert Einstein College of Medicine to pursuit her a PH.D. She was mentor by Dr. Frank Lily and learned mouse genetics from her and from that day Chen learned to perform her own animal studies.

After she obtain her PHD in genetics, she went to Columbia University for her postdoctoral training and she began her work on cell transformation and DNA tumor virus with the guidance of Dr. Robert Pollack. She worked in his laboratory and her job was to direct research activities of seven graduate students in his laboratory.

She became an assistant professor by Dr. Allan Conney, the chairman of the Department of Chemical Biology, School of Pharmacy, Rutgers University. She's been a faculty member at the School since 1992. When she began my position as assistant professor at Rutgers University she took project of regulating cell differentiation. She continued her studies in animals while making transgenic with the clone DNA to look for a generation of obese mice. She switched her research to melanoma and saw how GMR1 can play a role in human melanoma

Research
Chen's research is based on molecular mechanism of melanoma development using transgenic mouse model systems with the involvement of the Grm1; a G-protein-coupled receptor in control of cell growth and cell differentiation. Her ultimate goal is that for the next five years is to concentrate on human melanoma cells and hopes to find new ways to treat the disease.

Education & Training
PhD and MS. Albert Einstein College of Medicine, Bronx, NY

B.S. Trinity College, Hartford, CT

Post-Doctoral Fellowship. Columbia University, New York, NY

Awards

 * New Jersey Foundation Excellence in Research Award, 2021
 * -President-elect Pan American Society of Pigment Cell Research, 2019
 * Invited Speaker at Mini Symposium on Skin Cancer Seminar Series, Milton S. Hershey Medical Center, Hershey, PA, 2019
 * AAAS Fellow, "For significant contributions in translational research in melanoma biology, particularly for identifying the critical role of glutamatergic signaling in the etiology of melanoma", 2016
 * Invited Speaker at 4th GPCR in Drug Discovery, 2016
 * Speaker, Keystone Symposia on Molecular and Cell Biology, G protein-coupled receptors, structural dynamics and functional implications, Snowbird, UT, 2014
 * Second International Melanoma Congress Best Abstract Award, New York, NY, 2007
 * Rutgers University Board of Trustees Award for Excellence in Research, Piscataway, NJ, 2005
 * Keynote Speaker at Brain Tumor Center Seminar Series, MD Anderson Cancer Center, Huston, Tx, 2005

Scholarly Awards

 * 1) 2014 – present Council member of PanAmerican Society for Pigment Cell Research
 * 2) 2011 – present VA Oncology Study Section
 * 3) 2004 – present Member, NCI Special Emphasis Panel
 * 4) 2000 – present Planning and Review Committee for the Annual Retreat on Cancer Research
 * 5) 2004-2010 National Institute of Health Grant
 * 6) 2007-2012 National Institute of Health Grant
 * 7) 2009-2011 State of New Jersey Commission on Cancer Research Grant

Resources
Rutgers Enviornmental and Occuptional Health Sciences Institute Rutgers Sci Women Molecular Mechanisms of Melanoma Development Rutgers Ernest Mario School of Pharmacy

Publications

 * [1] Naczynski, D., Tan, M., Zevon, M. et al. Rare-earth-doped biological composites as in vivo shortwave infrared reporters. Nat Commun 4, 2199 (2013)
 * [https://www.nature.com/articles/ng1148 Pollock, Pamela M., et al. "Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia." Nature genetics 34.1 (2003): 108-112.


 * [2] Namkoong, Jin, et al. "Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma." Cancer research 67.5 (2007): 2298-2305.


 * [3]Umemura, Masanari, et al. "Store-operated Ca2+ entry (SOCE) regulates melanoma proliferation and cell migration." PloS one 9.2 (2014): e89292


 * [4] Marín, Yarí E., et al. "Curcumin downregulates the constitutive activity of NF-κB and induces apoptosis in novel mouse melanoma cells." Melanoma research 17.5 (2007): 274-283.


 * [ https://onlinelibrary.wiley.com/doi/full/10.1111/j.1755-148X.2008.00452.x] Shin, Seung‐Shick, et al. "Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation." Pigment cell & melanoma research 21.3 (2008): 368-378.


 * [5] Eddy, Kevinn, and Suzie Chen. "Overcoming immune evasion in melanoma." International journal of molecular sciences 21.23 (2020): 8984.
 * [6] Lumeng, J. Yu, et al. "Metabotropic glutamate receptors in cancer." Neuropharmacology 115 (2017): 193-202.


 * [7] Yip, Dana, et al. "A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma." Clinical Cancer Research 15.11 (2009): 3896-3902.

=References=